« Pfizer enters final settlements in 660 Chantix lawsuits | Main | Health ministry probes Diovan skin disruption reports »

July 23, 2013

Biogen says patient death unlikely linked to new MS drug

Quoted from http://www.reuters.com/article/2013/07/22/us-biogen-tecfidera-idUSBRE96L0UA20130722

Biogen says patient death unlikely linked to new MS drug

 

Mon Jul 22, 2013 5:48pm EDT

(Reuters) - The death of a patient who had taken Biogen Idec Inc's new multiple sclerosis drug, Tecfidera, was unlikely to be linked to the medicine, the company said on Monday. 

Biogen said it was made aware last week of the death of a 59-year-old woman who had been treated with Tecfidera, and that it was actively gathering facts about the case. 

Based on the circumstances of the case and the cause of death, "a link to Tecfidera is unlikely," said Biogen spokeswoman Kate Niazi-Sai. 

"The patient was not on Tecfidera at the time of death," she added.

[Article continues at original source]

Posted at 12:22 PM in Tecfidera |

Tags: adverse reactions, Biogen Idec, drug injury, multiple sclerosis drug, Tecfidera

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required